For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

In Virginia, health statistics show more than 20,000 people depend on dialysis and just a few thousand fewer have had kidney ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor ...

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and hyperphosphatemiaFinal European Commission decision ...

In patients with heart failure with preserved ejection fraction and obesity, tirzepatide improved clinical outcomes compared ...

“A holistic approach to care helps deliver better treatment and reduce the sense of overwhelm patients report about managing multiple chronic health conditions.” "People living with kidney disease are ...

By the time you graduate medical school, you should have a handle on these chronic diseases, as you’ll likely encounter them ...

Anyone who has diabetes, high blood pressure, heart problems or has a family history of the disease is at increased risk for ...

Black Americans face four times higher risk of kidney disease, with thousands undiagnosed due to healthcare gaps. Experts ...

According to the CDC, around 37 million American adults have chronic kidney disease, and millions more are at risk of developing it.